US2016237101A9PendingUtilityA9

Imidazolidine-based metal carbene metathesis catalysts

66
Assignee: CALIFORNIA INST OF TECHNPriority: May 24, 1999Filed: Aug 15, 2014Published: Aug 18, 2016
Est. expiryMay 24, 2019(expired)· nominal 20-yr term from priority
C07F 15/0046B01J 31/2273B01J 2531/825C08G 61/08B01J 2231/543B01J 31/2278B01J 31/2295B01J 2531/821
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel metathesis catalysts with an imidazolidine-based ligand and to methods for making and using the same. The inventive catalysts are of the formula wherein: M is ruthenium or osmium; X and X 1 are each independently an anionic ligand; L is a neutral electron donor ligand; and, R, R 1 , R 6 , R 7 , R 8 , and R 9 are each independently hydrogen or a substituent selected from the group consisting of C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, aryl, C 1 -C 20 carboxylate, C 1 -C 20 alkoxy, C 2 -C 20 alkenyloxy, C 2 -C 20 alkynyloxy, aryloxy, C 2 -C 20 alkoxycarbonyl, C 1 -C 20 alkylthiol, aryl thiol, C 1 -C 20 alkylsulfonyl and C 2 -C 20 alkylsulfinyl, the substituent optionally substituted with one or more moieties selected from the group consisting of C 1 -C 10 alkyl, C 1 -C 10 alkoxy, aryl, and a functional group selected from the group consisting of hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen. The inclusion of an imidazolidine ligand to the previously described ruthenium or osmium catalysts has been found to dramatically improve the properties of these complexes. The inventive catalysts maintains the functional group tolerance of previously described ruthenium complexes while having enhanced metathesis activity that compares favorably to prior art tungsten and molybdenum systems.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A compound of the formula 
       
         
           
           
               
               
           
         
       
       wherein:
 M is ruthenium or osmium; 
 X and X 1  are each independently an anionic ligand; 
 L is a neutral electron donor ligand; and, 
 R, R 1 , R 6 , R 7 , R 8 , and R 9  are each independently hydrogen or a substituent selected from the group consisting of C 1 -C 20  alkyl, C 2 -C 20  alkenyl, C 2 -C 20  alkynyl, aryl, C 1 -C 20  carboxylate, C 1 -C 20  alkoxy, C 2 -C 20  alkenyloxy, C 2 -C 20  alkynyloxy, aryloxy, C 2 -C 20  alkoxycarbonyl, C 1 -C 20  alkylthiol, aryl thiol, C 1 -C 20  alkylsulfonyl and C 1 -C 20  alkylsulfinyl, the substituent optionally substituted with one or more moieties selected from the group consisting of C 1 -C 10  alkyl, C 1 -C 10  alkoxy, aryl, and a functional group selected from the group consisting of hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, and halogen.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.